Danaher Completes Acquisition of Abcam
- None.
- None.
The acquisition of Abcam for
The consideration due to former Abcam shareholders will be settled pursuant to the terms of the Scheme and the consideration due to former Abcam ADS holders will be settled by the Depositary pursuant to the terms of the Deposit Agreement, in each case as further described in the shareholder circular relating to the Scheme, which was published by Abcam on October 5, 2023.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our 65,000+ associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W,
View original content:https://www.prnewswire.com/news-releases/danaher-completes-acquisition-of-abcam-302007456.html
SOURCE Danaher Corporation
FAQ
What is the latest acquisition by Danaher Corporation (NYSE:DHR)?
How was the acquisition of Abcam plc (NASDAQ:ABCM) implemented?
What is the status of Abcam plc (NASDAQ:ABCM) after the acquisition by Danaher Corporation (NYSE:DHR)?